使用下一代测序识别新型HLA-DPA1*02:112等位基因的鉴定
Jeongyun Bae1, Jun Young Hong1, Sunmi Jung2
1Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
HLA
|July 9, 2025
概括
一个新的人类白细胞抗原 (HLA) 基因,HLA-DPA1*02:112,已被确定. 它因单个核酸突变而与已知的等位基因不同.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 人类白细胞抗原 (HLA) 系统
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应中起着至关重要的作用.
- 准确的HLA等位基因鉴定对于移植和疾病关联研究至关重要.
- 在HLA基因内的遗传变异有助于免疫多样性.
研究的目的:
- 报告一个新的HLA-DPA1等位基因的发现和表征.
- 详细说明区分这种新型等位基因与之前描述的特定遗传差异.
主要方法:
- 使用了高分辨率的HLA排版技术.
- 用DNA测序来分析特定的遗传变异.
- 将新序列与现有的HLA等位基因数据库进行比较.
主要成果:
- 一个新的等位基因被确定,被指定为HLA-DPA1*02:112.
- 这种等位基因因与HLA-DPA1*02:02:02:01的区别在于,在第2个异位基因中,在第29个代号的单个核酸替代.
- 鉴定的核酸变化导致HLA-DPA1*02:112.12的独特遗传特征.
结论:
- 鉴定HLA-DPA1*02:112扩大了已知的HLA-DPA1位点的多样性.
- 这一发现有助于更全面地了解HLA多态性.
- 对新型HLA等位基因的准确报告对于免疫学和临床应用至关重要.
相关概念视频
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...


